Last reviewed · How we verify
NCT03721536: Oxygenation
Effects of Low-Flow Anesthesia on Hemodynamic Parameters and Oxygenation in Morbidly Obese Patients
NA trial testing hemodynamic parameters in Morbid Obesity in 48 participants. Completed in 1 November 2018.
30 October 2018
Quick facts
| Lead sponsor | Inonu University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 48 |
| Start date | 18 October 2018 |
| Primary completion | 30 October 2018 |
| Estimated completion | 1 November 2018 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- hemodynamic parameters
- arterial blood gase
Conditions studied
- Morbid Obesity — all drugs for Morbid Obesity →
- Hemodynamic Instability — all drugs for Hemodynamic Instability →
- Bariatric Surgery Candidate — all drugs for Bariatric Surgery Candidate →
Sponsor
Inonu University
Who can join
Adults 18 to 65, any sex, with Morbid Obesity or Hemodynamic Instability. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Low-flow anesthesia has been used for years with positive results, but its effects on hemodynamic parameters and oxygenation are not clearly known in high-risk morbidly obese patients who are prone to pulmonary dysfunction related to the obesity. Therefore, this prospective randomized study aimed to compare the effects of low-flow (0.75 L/min) and normal-flow (1.5 L/min) anesthesia on hemodynamic parameters and oxygenation in morbidly obese patients undergoing laparoscopic bariatric surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03721536
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Morbid Obesity
Currently open trials in the same condition.
- NCT06689241 — Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery · NA · recruiting
- NCT06413264 — Ultrasonography Guided Pneumoperitoneum for Laparoscopic Surgery in Morbidly Obese Patients · NA · recruiting
- NCT07289555 — Tailored Stapled SADI-S: Initial Report and Preliminary Results · NA · recruiting
- NCT07263269 — Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in · NA · active not recruiting
- NCT06293703 — Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study) · NA · recruiting
Other Inonu University trials
Trials by the same sponsor.
- NCT06553807 — Genital Self İmage and Satisfaction With Genital Appearance · NA · not yet recruiting
- NCT07480122 — Motor Imaging, Neglect, and Upper Extremity Function in Stroke · not yet recruiting
- NCT07463326 — The Efficacy of Transcutaneous Tibial Nerve Stimulation in Women With Idiopathic Overactive Bladder · NA · enrolling by invitation
- NCT07510737 — The Effect of Cross Training on Clinical and Functional Outcomes in Frozen Shoulder Rehabilitation · not yet recruiting
- NCT07530211 — The Effect of Systemic Factors on Peri-implant Health Status and Clinical Indices · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03721536 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Inonu University
- Last refreshed: 7 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03721536.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing